ARCHIVES

About Face; NCI To Keep Preclinical AIDS Drug Development

This article is from The Cancer Letter archive.

Vol. 12 No. 48 | December 12, 1986

Download PDF Visit The Full Archive

Related Articles

Virus Studies Approved By DCE Board for $2.5 Mil. In First Year

November 3, 1989

In Brief: No Such Thing As Premature Data, Fisher Says- Only Immature Evaluation, Premature Application

June 20, 1980

FDA Approves Erbitux for Head & Neck Cancer.

March 3, 2006

ACS to Being Review Of Facilities Survey Proposals; Working Group Established

May 25, 1984

The Donald Pinkel Archive

May 21, 2021

DCBD Board Okays Concept For New Cytogenetics RFA

August 3, 1984